Table 6 Application of LPHNPs for the treatment of melanoma
Sr. No | Lipid component | Polymer component | Targeting moiety | Drug | In vitro | In vivo | Ref |
|---|---|---|---|---|---|---|---|
1 | DSPE-PEG, HSPC | PLGA | _ | DOX | M14 melanoma cells | _ | [276] |
2 | HSPC, Cholesterol, DSPE-PEG-2000 | PLGA | Vitamin D | Fluorescein | B16 | _ | [277] |
3 | Lecithin, cholesterol | mPEG-PLGA | RGD | CUR | B16 | female BALB/c mice | [278] |
4 | Hydrogenated phosphatidylcholine, DSPE-PEG2K-Maleimide | PLGA | Transferrin | Plumbagin | B16F10 | female BALB/c mice | [279] |